Abu Dhabi |
F82-2421-05564-01 |
897 |
AED |
|
Novartis |
Capsule, hard |
0.25mg |
10 |
10's |
Oral |
Topotecan |
L01XX17 |
|
27/01/2021 |
Abu Dhabi |
F76-2421-05565-01 |
2052.75 |
AED |
|
Novartis |
Capsule, hard |
1mg |
10 |
10's Blister |
Oral |
Topotecan |
L01XX17 |
|
27/01/2021 |
Abu Dhabi |
F76-2421-05566-01 |
883.2 |
AED |
|
Novartis |
Powder for solution for injection |
1mg |
1 |
1 Vial |
|
Topotecan |
L01XX17 |
|
27/01/2021 |
Czech Republic |
29337 |
2359.69 |
CZK |
|
Novartis Europharm Limited, Dublin |
Capsule, hard |
0.25mg |
10 |
0,25mg CPS DUR 10 |
Oral |
Topotecan |
L01XX17 |
|
28/02/2020 |
Czech Republic |
29338 |
8788.99 |
CZK |
|
Novartis Europharm Limited, Dublin |
Capsule, hard |
1mg |
10 |
1mg CPS DUR 10 |
Oral |
Topotecan |
L01XX17 |
|
28/02/2020 |
Denmark |
090762 |
1404 |
DKK |
|
Sandoz |
Capsule, hard |
0.25mg |
10 |
10 stk. (blister) |
|
Topotecan |
L01XX17 |
|
19/05/2021 |
Denmark |
128182 |
5595.5 |
DKK |
|
Sandoz |
Capsule, hard |
1mg |
10 |
10 stk. (blister) |
|
Topotecan |
L01XX17 |
|
19/05/2021 |
Denmark |
126385 |
|
DKK |
|
Novartis |
Capsule, hard |
0.25mg |
10 |
10 stk. (blister) |
|
Topotecan |
L01XX17 |
|
19/05/2021 |
Denmark |
126374 |
|
DKK |
|
Sandoz |
Capsule, hard |
1mg |
10 |
10 stk. (blister) |
|
Topotecan |
L01XX17 |
|
19/05/2021 |
Denmark |
454850 |
|
DKK |
|
Sandoz |
Powder for Concentrate for solution for infusion |
4mg |
1 |
1 stk. |
|
Topotecan |
L01XX17 |
|
19/05/2021 |
Finland |
165985 |
|
EUR |
|
Orifarm |
Powder for concentrate for solution for infusion |
4mg |
1 |
1kpl |
|
Topotecan |
L01XX17 |
Vial |
22/04/2021 |
Finland |
165986 |
|
EUR |
|
Orifarm |
Powder for concentrate for solution for infusion |
4mg |
5x4mg |
1kpl |
|
Topotecan |
L01XX17 |
Vial |
22/04/2021 |
Finland |
19490 |
|
EUR |
|
Novartis |
Powder for solution for injection |
1mg |
1 |
1kpl |
|
Topotecan |
L01XX17 |
Vial |
22/04/2021 |
Finland |
19491 |
|
EUR |
|
Novartis |
Powder for solution for injection |
1mg |
5 |
1kpl |
|
Topotecan |
L01XX17 |
Vial |
22/04/2021 |
Finland |
9141 |
|
EUR |
|
Novartis |
Powder for solution for injection |
4mg |
5 |
1kpl |
|
Topotecan |
L01XX17 |
Vial |
22/04/2021 |
Finland |
95829 |
|
EUR |
|
Novartis |
Capsule, hard |
0.25mg |
10 |
10kpl |
|
Topotecan |
L01XX17 |
Blister |
22/04/2021 |
Finland |
95830 |
|
EUR |
|
Novartis |
Capsule, hard |
1mg |
10 |
10kpl |
|
Topotecan |
L01XX17 |
Blister |
22/04/2021 |
Finland |
192041 |
|
EUR |
|
Orifarm |
capsule, hard |
1mg |
10 |
10kpl |
|
Topotecan |
L01XX17 |
Blister |
22/04/2021 |
Finland |
154160 |
|
EUR |
|
Paranova |
capsule, hard |
1mg |
10 |
10kpl |
|
Topotecan |
L01XX17 |
Blister |
22/04/2021 |
Ireland |
88585 |
534.34 |
EUR |
|
Novartis |
Capsule, hard |
1mg |
10 |
|
|
Topotecan |
L01XX17 |
|
08/10/2020 |
Ireland |
88560 |
130.54 |
EUR |
|
Novartis |
Capsule, hard |
0.25mg |
10 |
|
|
Topotecan |
L01XX17 |
|
08/10/2020 |
Italy |
33306061 |
142.88 |
EUR |
|
Novartis |
Capsule, hard |
0.25mg |
10 |
|
Oral |
Topotecan |
L01XX17 |
TOPOTECAN 0,25MG 10 UNITA' USO ORALE |
17/12/2019 |
Italy |
33306073 |
571.52 |
EUR |
|
Novartis |
Capsule, hard |
1mg |
10 |
|
Oral |
Topotecan |
L01XX17 |
TOPOTECAN 1MG 10 UNITA' USO ORALE |
17/12/2019 |
Norway |
090762 |
1443 |
NOK |
|
Novartis Europharm Limited (1) |
Capsule, hard |
0.25mg |
10 |
Blisterpakning |
|
Topotecan |
L01XX17 |
Blisterpakning/1/10/stk |
01/04/2020 |
Norway |
128182 |
5663.1 |
NOK |
|
Novartis Europharm Limited (1) |
Capsule, hard |
1mg |
10 |
Blisterpakning |
|
Topotecan |
L01XX17 |
Blisterpakning/1/10/stk |
01/04/2020 |
Norway |
454850 |
3590.2 |
NOK |
|
Novartis Europharm Limited (1) |
powder for concentrate for Solution pour perfusion |
4mg |
1 |
Flacon en verre |
|
Topotecan |
L01XX17 |
Hetteglass//1/stk |
01/04/2020 |
Sweden |
20070709100046 |
2159.69 |
SEK |
|
Novartis Sverige AB |
Capsule, hard |
0.25mg |
10 |
10 kapslar |
|
Topotecan |
L01XX17 |
Blister |
23/04/2020 |
Sweden |
20070709100053 |
8500.01 |
SEK |
|
Novartis Sverige AB |
Capsule, hard |
1mg |
10 |
10 kapslar |
|
Topotecan |
L01XX17 |
Blister |
23/04/2020 |